This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

BUSINESS

Daiichi Sankyo Looks to Bring Annual 8-10 Projects into Clinical Phase, Open Innovation Key to Success: R&D Execs

Daiichi Sankyo hopes to see eight to 10 research projects enter the clinical development stage each year throughout its five year business plan ending 2017, Glenn Gormley, global head of ... > Read full story
BUSINESS
Pharmacist Society Criticizes Inappropriate Phrases in Materials Used by Sales Reps, Questions Use of Misleading Terms (Dec.19)
BUSINESS
CRO Intellim to Collaborate with Indian Firm for CDISC (Dec.18)
REGULATORY
MHLW Releases Discussion Outline of ICH Lisbon Meeting (Dec.18)
BUSINESS
Novartis Confirms Additional Cases of Employee Involvement in IIT, but Denies Falsification or Manipulation of Data (Dec.18)
BUSINESS
Ribomic to Extend Joint Research Term by 1 Year with Otsuka for Hematological Disorder, Fibrosis Projects (Dec.18)
> More Latest News

Photosmore

  
CRO Intellim to Collaborate with Indian Firm for CDISC (Dec.18)Chugai to File for Approval of Xeloda as Gastric Cancer Adjuvant Therapy by Year-End (Dec.17)With Mandatory CDISC-Based Submission Looming, CRO A2 Sees Soaring Orders from Japanese Drug Makers (Dec.16)
  
JPMA Will Work to Secure Quality, Transparency of Clinical Research for Purpose of Advertising: Vice President (Dec.15)LDP Healthcare Big Names Cruise to Victory in Lower House Poll (Dec.15)Kyowa Kirin Aims to Score Global Sales of 20 Billion Yen for Poteligeo in a Few Years: President Hanai (Dec.15)

News Categories

REGULATORY
   MHLW Releases Discussion Outline of ICH Lisbon Meeting(Dec.18)
   LDP Tax Panel Execs Eye Slight Cut of R&D Tax Deduction Cap(Dec.17)
   Drug Makers Present Cases in Which PI Trials in Japanese Could Be Omitted in Multinational Studies: PMDA Workshop(Dec.17)
BUSINESS
   Pharmacist Society Criticizes Inappropriate Phrases in Materials Used by Sales Reps, Questions Use of Misleading Terms(Dec.19)
   Daiichi Sankyo Looks to Bring Annual 8-10 Projects into Clinical Phase, Open Innovation Key to Success: R&D Execs(Dec.18)
   CRO Intellim to Collaborate with Indian Firm for CDISC(Dec.18)
ORGANIZATION
   JMA Chief Lauds Big Win by LDP, Komeito in Lower House Race(Dec.17)
   JPMA to Require Disclosure of Clinical R&D Costs in More Detail(Dec.15)
   JMA, JAMS Call for Enhancing Support for Girls Suffering from Post-HPV Vaccine Reactions(Dec.12)
ACADEMIA
   Jikei Concludes Event Data Unnatural in Diovan Study(Dec.15)
   British Medical Journal Retracts Sub-Analysis Paper of VART Study(Dec.11)
   Cancer Researchers Call for Academia-Industry Collaboration via Japan NIH(Dec.09)

Commentary

April-Sept. Earnings Signal Watershed in Japan’s Shift to Generics

Lexicon

Pharmaceuticals and Medical Devices Law:
薬機法

The Column

What You Don’t Know About Communication Can Hurt You

Archives

LDP Tax Panel Execs Eye Slight Cut of R&D Tax Deduction Cap(Dec.17)
Drug Makers Present Cases in Which PI Trials in Japanese Could Be Omitted in Multinational Studies: PMDA Workshop(Dec.17)
Chugai to File for Approval of Xeloda as Gastric Cancer Adjuvant Therapy by Year-End(Dec.17)
JMA Chief Lauds Big Win by LDP, Komeito in Lower House Race(Dec.17)
Xtandi Demonstrates Clinical Benefit for Advanced Breast Cancer in PII Study: Astellas(Dec.17)

Most Read

1.
Elplat, Elaspol...
2.
Astellas Reduce...
3.
Panel Reveals F...
4.
Sales of Biosim...
5.
Outline of New ...

News Calendar